Juan Carlos Balandran
Overview
Explore the profile of Juan Carlos Balandran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Nunez-Enriquez J, Romo-Rodriguez R, Gaspar-Mendoza P, Zamora-Herrera G, Torres-Pineda L, Amador-Cardoso J, et al.
Front Oncol
. 2024 Apr;
14:1304690.
PMID: 38634051
The main objective of the National Project for Research and Incidence of Childhood Leukemias is to reduce early mortality rates for these neoplasms in the vulnerable regions of Mexico. This...
3.
Romo-Rodriguez R, Zamora-Herrera G, Lopez-Blanco J, Lopez-Garcia L, Rosas-Cruz A, Alfaro-Hernandez L, et al.
Front Oncol
. 2024 Jan;
13:1304662.
PMID: 38250553
Introduction: The decisive key to disease-free survival in B-cell precursor acute lymphoblastic leukemia in children, is the combination of diagnostic timeliness and treatment efficacy, guided by accurate patient risk stratification....
4.
Barrios-Palacios D, Organista-Nava J, Balandran J, Alarcon-Romero L, Zubillaga-Guerrero M, Illades-Aguiar B, et al.
Int J Mol Sci
. 2024 Jan;
25(1).
PMID: 38203290
Acute lymphoblastic leukemia (ALL) is the most common cancer in children worldwide. Although ALL patients' overall survival rates in wealthy countries currently surpass 80%, 15-20% of patients still experience relapse....
5.
Balandran J, Lasry A, Aifantis I
Blood Cancer Discov
. 2023 Apr;
4(4):254-266.
PMID: 37052531
Significance: Inflammation is emerging as an important factor in myeloid malignancies. Understanding the role of inflammation in myeloid transformation, and the interplay between inflammation and other drivers of leukemogenesis, may...
6.
Romo-Rodriguez R, Gutierrez-de Anda K, Lopez-Blanco J, Zamora-Herrera G, Cortes-Hernandez P, Santos-Lopez G, et al.
Arch Med Res
. 2023 Mar;
54(3):197-210.
PMID: 36990888
Background And Aims: Mexico is among the countries with the highest estimated excess mortality rates due to the COVID-19 pandemic, with more than half of reported deaths occurring in adults...
7.
Balandran J, Zamora-Herrera G, Romo-Rodriguez R, Pelayo R
J Interferon Cytokine Res
. 2022 Jun;
42(8):393-405.
PMID: 35675647
The recognition of pathogens to which we are constantly exposed induces the immediate replenishment of innate immune cells from the most primitive stages of their development through emergency hematopoiesis, a...
8.
Rios de Los Rios J, Enciso J, Vilchis-Ordonez A, Vazquez-Ramirez R, Ramirez-Ramirez D, Balandran J, et al.
J Leukoc Biol
. 2022 Jun;
112(1):31-45.
PMID: 35674096
Leukemogenesis is proposed to result from the continuous interplay between inducive bone marrow (BM) microenvironments and malignant precursor cells. Recent findings point toward an abnormal production of proinflammatory mediators within...
9.
Pinho S, Wei Q, Maryanovich M, Zhang D, Balandran J, Pierce H, et al.
Nat Cell Biol
. 2022 Feb;
24(3):290-298.
PMID: 35210567
Haematopoietic stem cells (HSCs) home to the bone marrow via, in part, interactions with vascular cell adhesion molecule-1 (VCAM1). Once in the bone marrow, HSCs are vetted by perivascular phagocytes...
10.
Balandran J, Davila-Velderrain J, Sandoval-Cabrera A, Zamora-Herrera G, Teran-Cerqueda V, Garcia-Stivalet L, et al.
Front Immunol
. 2021 Nov;
12:746492.
PMID: 34737747
B-cell acute lymphoblastic leukemia (B-ALL) results from the expansion of malignant lymphoid precursors within the bone marrow (BM), where hematopoietic niches and microenvironmental signals provide leukemia-initiating cells (LICs) the conditions...